SARS-CoV-2

Differing opinions about the Lambda variant

Differing opinions about the Lambda variant: Super mutant, successor to Delta or damp squib? For the first time since the SARS-CoV-2 Task Force was established 18 months ago, a difference of opinion has arisen, specifically with regard to the Lambda variant. What everyone agrees on is that the Lambda or C.37 variant is clearly more…

Read More

The SARS-CoV-2 T-Cell immunity analysis is to be integrated into our Covid-19 Immunization Program

The SARS-CoV-2 T-Cell immunity analysis is to be integrated into our Covid-19 Immunization Program for clients with immediate effect. So far, we have been testing only one of the two immunity pillars, namely antibody production. In addition to checking the full range of antibodies, Dr Robert Hess goes far beyond the generally applied classification to…

Read More

We are now several months into the vaccination campaign

We are now several months into the vaccination campaign, and it is clear to us from our own SARS-CoV-2 antibody and immunization testing that the track record of the vaccines is very disappointing, with more side-effects than originally expected. We therefore intend to have a personalized vaccine combination in place for 2022. It is the…

Read More